サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1562204

アジア太平洋の変形性関節症治療：2030年市場予測- 地域別分析：治療タイプ、適応疾患、エンドユーザー別

Asia Pacific Osteoarthritis Therapy Market Forecast to 2030 - Regional Analysis - by Therapy Type, Disease Indication, and End User

出版日
ページ情報
英文 114 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
アジア太平洋の変形性関節症治療：2030年市場予測- 地域別分析：治療タイプ、適応疾患、エンドユーザー別
出版日: 2024年07月04日
発行: The Insight Partners
ページ情報: 英文 114 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の変形性関節症治療市場は、2022年に37億781万米ドルと評価され、2030年には70億3,700万米ドルに達すると予測され、2022年から2030年までのCAGRは8.3%と推定されます。

薬への依存を減らす革新的な治療法がアジア太平洋の変形性関節症治療市場を押し上げる

非薬物療法はOA治療の重要な側面です。生活習慣の改善や薬物療法に加え、OAを患う患者には、ホットパックやコールドパック、補助器具など、さまざまな支持療法が有効です。さらに、栄養補助食品やルベファシエントなどの補完代替療法もOAの管理に役立ちます。さらに、局所治療、指導付きエクササイズ、神経筋トレーニング、自己管理、患者教育、減量介入などがOAに適した治療法のひとつです。

変形性膝関節症（OKP）の治療では、膝装具が膝の痛みを軽減するために使用されます。装具は軟部組織を圧迫し、膝を安定させ、体重を分散させます。膝装具の例としては、圧迫スリーブ、ヒンジ式膝装具、アンローダー膝装具などがあります。また、これらの圧迫装具は、ドラッグストアや薬局、オンラインチャネルで簡単に入手できます。そのため、革新的な治療オプションが利用可能になることで、薬への依存度が下がり、変形性関節症治療市場の成長を後押ししています。

アジア太平洋の変形性関節症治療市場概要

アジア太平洋の変形性関節症治療市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。変形性関節症治療薬の臨床試験を実施するための患者の確保が、予測期間中の市場成長に最も影響する要因です。また、患者の臨床試験を実施するための政府の支援は、今後数年間の市場成長をさらに促進します。Frontiers S.A.の報告書によると、高齢化率が高い中国では、変形性膝関節症が障害の主な原因となっており、中国の人々の間で莫大なヘルスケアコストの負担となっています。また、米国国立衛生研究所（NIH）の報告によると、中国の農村部では症候性膝関節症が多く（16.57％）、この発症率は70歳以上の人口で著しく増加しています（女性29.25％、男性24.71％）。例えば、鍼治療や太極拳は膝関節症に対する非外科的治療法です。さらに、中国における膝関節症治療の非薬物療法は、中国人の痛みと障害を軽減するための集学的アプローチを重視しています。非薬物療法には、患者教育、作業療法、理学療法、有酸素運動、社会的支援、減量などが含まれます。また、中国人の膝関節症は、単純鎮痛薬やオピオイド鎮痛薬、COX-2選択的阻害薬を含む非ステロイド性抗炎症薬（NSAIDs）、グルココルチコイドやヒアルロン酸製剤などの注射薬などの薬物療法によって治療されています。高齢化が進む中国の人口の間で膝関節症の有病率が上昇しており、革新的な治療オプションに対する需要が加速し、2022～2030年の市場成長を支配しています。

アジア太平洋の変形性関節症治療市場の収益と2030年までの予測（金額）

アジア太平洋の変形性関節症治療市場のセグメンテーション

アジア太平洋の変形性関節症治療市場は、治療タイプ、適応疾患、エンドユーザー、国別に分類されます。

治療タイプ別に見ると、アジア太平洋の変形性関節症治療市場は、経皮的電気神経刺激（TENS）、作業療法、理学療法、多血小板血漿（PRP）療法＆間質血管分画、プロロセラピー、その他に区分されます。理学療法分野が2022年に最大の市場シェアを占めました。

疾患適応の観点から、アジア太平洋の変形性関節症治療市場は、変形性膝関節症、変形性脊椎症、変形性足関節症、変形性肩関節症、変形性手関節症、その他に区分されます。変形性膝関節症セグメントは、2022年のアジア太平洋の変形性関節症治療市場で最大のシェアを占めました。

エンドユーザー別に見ると、アジア太平洋の変形性関節症治療市場は、病院・クリニック、専門クリニック、外来手術センター、在宅ケア、その他に分類されます。2022年のアジア太平洋の変形性関節症治療市場は、在宅ケア分野が最大シェアを占めました。

国別では、アジア太平洋の変形性関節症治療市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。2022年のアジア太平洋の変形性関節症治療市場シェアは中国が独占しました。

Zimmer Biomet Holdings Inc、DePuy Synthes Inc、Bioventus Inc、Omron Healthcare Inc、Exactech Inc、Medi GmbH &Co KG、Zealmax Innovations Pvt Ltdは、アジア太平洋の変形性関節症治療市場で事業を展開している主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 変形性関節症治療市場情勢

  • パイプライン分析
    • 臨床試験パイプライン分析

第5章 アジア太平洋の変形性関節症治療市場-主要市場力学

  • 市場促進要因
    • 変形性関節症の有病率の上昇
    • 革新的な治療オプションによる薬物依存の軽減
  • 市場抑制要因
    • 製品回収
  • 市場機会
    • 再生医療の利用可能性
  • 今後の動向
    • より効果的な治療オプション
  • 促進要因と抑制要因の影響

第6章 アジア太平洋の変形性関節症治療市場：市場分析

    • 変形性関節症治療薬市場の売上高、2020年～2030年

第7章 アジア太平洋の変形性関節症治療市場分析：治療タイプ別

  • 経皮的電気神経刺激療法（TENS）
  • 作業療法
  • 理学療法
  • 血小板リッチ血漿療法と間質血管画分
  • プロロセラピー
  • その他

第8章 アジア太平洋の変形性関節症治療市場分析：適応疾患別

  • 変形性膝関節症
  • 脊椎変形性関節症
  • 変形性足関節症
  • 肩変形性関節症
  • 手の変形性関節症
  • その他

第9章 アジア太平洋の変形性関節症治療市場分析：エンドユーザー別

  • 病院およびクリニック
  • 専門クリニック
  • 外来手術センター
  • 在宅医療
  • その他

第10章 アジア太平洋の変形性関節症治療市場：国別分析

  • アジア太平洋市場の概要
    • アジア太平洋地域
      • 中国
      • 日本
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋地域

第11章 業界情勢

  • 変形性関節症治療市場における成長戦略
  • 有機的展開
  • 無機的展開

第12章 企業プロファイル

  • Zimmer Biomet Holdings Inc
  • DePuy Synthes Inc
  • Bioventus Inc
  • Omron Healthcare Inc
  • Exactech Inc
  • Medi GmbH & Co KG
  • Zealmax Innovations Pvt Ltd

第13章 付録

図表

List Of Tables

  • Table 1. Osteoarthritis Therapy Market Segmentation
  • Table 2. Ongoing Clinical Trial of Osteoarthritis
  • Table 3. China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
  • Table 4. China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
  • Table 5. China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 6. Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
  • Table 7. Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
  • Table 8. Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 9. India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
  • Table 10. India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
  • Table 11. India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 12. Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
  • Table 13. Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
  • Table 14. Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 15. South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
  • Table 16. South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
  • Table 17. South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 18. Rest of Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
  • Table 19. Rest of Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
  • Table 20. Rest of Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
  • Table 21. Organic Developments Done by Companies
  • Table 22. Inorganic Developments Done by Companies

List Of Figures

  • Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
  • Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
  • Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
  • Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
  • Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
  • Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Asia Pacific: Osteoarthritis Therapy Market - Revenue by Key Countries 2022 (US$ Million)
  • Figure 26. Asia Pacific: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 27. China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 29. India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 31. South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 32. Rest of Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 33. Growth Strategies in the Osteoarthritis Therapy Market
目次
Product Code: BMIRE00030376

The Asia Pacific osteoarthritis therapy market was valued at US$ 3,707.81 million in 2022 and is expected to reach US$ 7,037.00 million by 2030; it is estimated to register a CAGR of 8.3% from 2022 to 2030.

Innovative Therapy Options Reducing Dependency on Medications Boost Asia Pacific Osteoarthritis Therapy Market

The non-pharmacologic therapy is a key facet of treating OA. With lifestyle changes and medicines, patients suffering from OA may benefit from various supportive therapy options, including hot or cold packs and assistive devices. Additionally, complementary, and alternative therapy options such as nutritional supplements and rubefacients may help in managing OA. Further, topical treatments, supervised exercises, neuromuscular training, self-management, patient education, and weight loss intervention are among the best treatments suited for OA.

In osteoarthritis knee pain (OKP) treatment, knee braces are used to reduce knee pain as these braces may apply compression (pressure) to soft tissues, stabilize the knee, and redistribute weight. A few examples of knee braces are compression sleeves, hinged knee braces, and unloader knee braces. Also, these compression braces are easily available at drugstores, pharmacies, and online channels. Therefore, availability of innovative therapy options reduces dependency on medications, which drives the osteoarthritis therapy market growth.

Asia Pacific Osteoarthritis Therapy Market Overview

Asia Pacific osteoarthritis therapy market is segmented as China, Japan, India, Australia, South Korea, and Rest of Asia Pacific countries. The patients availability for conducting clinical trials to test drugs intended for osteoarthritis is the most influential factors responsible for market growth during the forecast period. Also, government support for conducting the patient's clinical trials further enhances the market growth during the coming years. According to the Frontiers S.A. report, with China having a high burden of an aging population, knee O.A. is the leading cause of disability, having a burden of huge healthcare costs among the Chinese population. Additionally, the National Institute of Health (NIH) reports that in rural China, symptomatic knee O.A. is more prevalent (16.57%), and this incidence has increased significantly among the population aged 70 years and older (29.25% among women and 24.71% among men). Therefore, traditional Chinese medicines (TCM) have been accepted as a complementary therapy for knee O.A. For example, acupuncture and Tai Chi are non-surgical treatment options for knee O.A. Additionally, non-pharmacological treatment options to treat knee O.A. in China emphasize a multidisciplinary approach to reduce pain and disability among the Chinese population. Non-pharmacological options include patient education, occupational and physical therapy, aerobic exercises, social support, and weight loss. Also, knee O.A. among the Chinese population is treated by pharmacological therapies such as simple and opioid analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), including COX-2 selective inhibitors, and injectable agents such as glucocorticoids and hyaluronan preparations. Therefore, the rising prevalence of knee O.A. among the aging Chinese population accelerates demand for innovative therapy options, dominating the market growth during the 2022-2030.

Asia Pacific Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Osteoarthritis Therapy Market Segmentation

The Asia Pacific osteoarthritis therapy market is categorized into therapy type, disease indications, end user, and country.

Based on therapy type, the Asia Pacific osteoarthritis therapy market is segmented into transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy & stromal vascular fraction, prolotherapy, and others. The physical therapy segment held the largest market share in 2022.

In terms of disease indications, the Asia Pacific osteoarthritis therapy market is segmented into knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. The knee osteoarthritis segment held the largest share of Asia Pacific osteoarthritis therapy market in 2022.

Based on end user, the Asia Pacific osteoarthritis therapy market is categorized into hospitals and clinics, specialty clinics, ambulatory surgical center, homecare, and others. The homecare segment held the largest share of Asia Pacific osteoarthritis therapy market in 2022.

By country, the Asia Pacific osteoarthritis therapy market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific osteoarthritis therapy market share in 2022.

Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, Exactech Inc, Medi GmbH & Co KG, and Zealmax Innovations Pvt Ltd are some of the leading companies operating in the Asia Pacific osteoarthritis therapy market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Osteoarthritis Therapy Market Landscape

  • 4.1 Pipeline Analysis
    • 4.1.1 Clinical Trial Pipeline Analysis

5. Asia Pacific Osteoarthritis Therapy Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Rising Prevalence of Osteoarthritis
    • 5.1.2 Innovative Therapy Options Reducing Dependency on Medications
  • 5.2 Market Restraints
    • 5.2.1 Product Recall
  • 5.3 Market Opportunities
    • 5.3.1 Availability of Regenerative Medicine
  • 5.4 Future Trends
    • 5.4.1 More Effective Treatment Options
  • 5.5 Impact of Drivers and Restraints:

6. Osteoarthritis Therapy Market - Asia Pacific Market Analysis

  • 6.1 Overview
    • 6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030

7. Asia Pacific Osteoarthritis Therapy Market Analysis - by Therapy Type

  • 7.1 Overview
  • 7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
    • 7.2.1 Overview
    • 7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Occupational Therapy
    • 7.3.1 Overview
    • 7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Physical Therapy
    • 7.4.1 Overview
    • 7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
    • 7.5.1 Overview
    • 7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Prolotherapy
    • 7.6.1 Overview
    • 7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Osteoarthritis Therapy Market Analysis - by Disease Indication

  • 8.1 Overview
  • 8.2 Knee Osteoarthritis
    • 8.2.1 Overview
    • 8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Spine Osteoarthritis
    • 8.3.1 Overview
    • 8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Foot and Ankle Osteoarthritis
    • 8.4.1 Overview
    • 8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Shoulder Osteoarthritis
    • 8.5.1 Overview
    • 8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Hand Osteoarthritis
    • 8.6.1 Overview
    • 8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Osteoarthritis Therapy Market Analysis - by End User

  • 9.1 Overview
  • 9.2 Hospitals and Clinics
    • 9.2.1 Overview
    • 9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.3 Specialty Clinics
    • 9.3.1 Overview
    • 9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Ambulatory Surgical Centers
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Homecare
    • 9.5.1 Overview
    • 9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Osteoarthritis Therapy Market - Country Analysis

  • 10.1 Asia Pacific Market Overview
    • 10.1.1 Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 China: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.1.3 China: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.1.1.1.4 China: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.1.1.1.5 China: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.1.1.2 Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Japan: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.2.3 Japan: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.1.1.2.4 Japan: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.1.1.2.5 Japan: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.1.1.3 India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 India: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.3.3 India: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.1.1.3.4 India: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.1.1.3.5 India: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.1.1.4 Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Australia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.4.3 Australia: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.1.1.4.4 Australia: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.1.1.4.5 Australia: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.1.1.5 South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 South Korea: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.5.3 South Korea: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.1.1.5.4 South Korea: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.1.1.5.5 South Korea: Osteoarthritis Therapy Market Breakdown, by End User
      • 10.1.1.6 Rest of Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Asia Pacific: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
        • 10.1.1.6.3 Rest of Asia Pacific: Osteoarthritis Therapy Market Breakdown, by Therapy Type
        • 10.1.1.6.4 Rest of Asia Pacific: Osteoarthritis Therapy Market Breakdown, by Disease Indication
        • 10.1.1.6.5 Rest of Asia Pacific: Osteoarthritis Therapy Market Breakdown, by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the osteoarthritis therapy market
  • 11.3 Organic Developments
    • 11.3.1 Overview
  • 11.4 Inorganic Developments
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Zimmer Biomet Holdings Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 DePuy Synthes Inc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Bioventus Inc
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Omron Healthcare Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Exactech Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Medi GmbH & Co KG
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Zealmax Innovations Pvt Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners